Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 19, 2018

DrugPatentWatch Database Preview

Actavis Llc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LLC, and what generic and branded alternatives to ACTAVIS LLC drugs are available?

ACTAVIS LLC has ten approved drugs.

There is one tentative approval on ACTAVIS LLC drugs.

Summary for Actavis Llc

US Patents:	0
Tradenames:	9
Ingredients:	9
NDAs:	10
Patent Litigation for Actavis Llc:	See patent lawsuits for Actavis Llc
PTAB Cases with Actavis Llc as petitioner:	See PTAB cases with Actavis Llc as petitioner

Drugs and US Patents for Actavis Llc

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Llc	LEVOLEUCOVORIN CALCIUM	levoleucovorin calcium	POWDER;INTRAVENOUS	208723-001	Sep 29, 2016		RX	Yes	Yes		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Llc	DAPSONE	dapsone	TABLET;ORAL	204380-001	Mar 23, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Llc	OXALIPLATIN	oxaliplatin	INJECTABLE;IV (INFUSION)	204880-001	Mar 5, 2018	AP	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Actavis Llc	DOCETAXEL	docetaxel	INJECTABLE;INJECTION	203551-001	Apr 12, 2013	AP	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office

US Department of Justice

Julphar

AstraZeneca

Deloitte

Accenture

Daiichi Sankyo

Merck

Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.